Results 21 to 30 of about 3,310,854 (363)

Update on pharmacotherapy in psychodermatological disorders

Indian Dermatology Online Journal, 2020
Psychodermatological (PD) conditions encountered in dermatologic practice include primary psychiatric conditions such as delusions of parasitosis or secondary psychiatric conditions such as anxiety and depression due to dermatologic disease.
Shrutakirthi D Shenoi, Savitha Soman, Ravindra Munoli, Smitha Prabhu   +3 more
doaj   +1 more source

Do you know this syndrome? Hand-foot syndrome [PDF]

Anais Brasileiros de Dermatologia, 2017
Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces.
Cintia Santos Braghiroli, Rodrigo Ieiri, Juliana Polizel Ocanha, Rafael Bispo Paschoalini, Hélio Amante Miot   +4 more
doaj   +2 more sources

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K., Anderson, J., Andrews, S., Arrindell, D., Ballesteros, J., Bingham, C. O., Boyer, J., Brogdon, C., Chen, D., Chonzi, D., Cotarla, I., Cunha, R., Dadu, R., Davies, M., Dawson, M., Diab, A., Dicker, Adam, Eifler, L., Ernstoff, M. S., Ferguson, A., Ferlini, C., Frankel, S., Go, W., Gochett, C., Goldberg, J., Goncalves, P., Goswami, T., Gregory, N., Gulley, J. L., Hamad, L., Hayreh, V., Helie, N., Holmes, W., Hsu, J. Y., Ibrahim, R., Kaufman, H. L., Kim, S., Lacouture, M. E., Lambotte, O., Larocca, C., LeBoeuf, N. R., Lehman, K., Lenihan, D., Ley-Acosta, S., Luke, J., McClure, J., Michelon, E., Nakamura, M., Onofrei, C., Patel, K., Piperdi, B., Puzanov, I., Rasheed, Z., Reshef, D., Riemer, J., Robert, C., Sarkeshik, M., Saylors, A., Schreiber, J., Shafer-Weaver, K., Shannon, V., Sharfman, W., Sharma, R., Sharon, E., Sherry, R., Silk, A. W., Simonson, C., Skondra, D., Suarez-Almazor, M. E., Thomas, C., Thompson, J. A., Trehu, E., Tresnan, D., Turner, M., Wang, Y., Wariabharaj, D., Waxman, I., Wiley, K., Wood, L., Zhang, L., Zheng, P.   +80 more
core   +2 more sources

Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial [PDF]

, 2016
published_or_final_versio
Chan, SM, Lao, L, Lee, SMD, Wong, MK, Yeung, WF, YOU, J   +5 more
core   +3 more sources

Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018
Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
V. А. Solodovnyk, N. О. Tkachenko, S. А. Gladysheva   +2 more
doaj   +1 more source

The effect of isotretinoin on triglycerides and liver aminotransferases Influência da isotretinoína nas transaminases hepáticas e triglicerídeos

Anais Brasileiros de Dermatologia, 2012
BACKGROUND: Isotretinoin has been used to treat the most severe cases of acne; however, it may provoke adverse events in mucocutaneous and hepatic tissues, lead to alterations in lipid levels and cause teratogenicity.
Andreia Salezze Vieira, Vanessa Beijamini, Ana Carolina Melchiors   +2 more
doaj   +1 more source

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis

International Journal of Rheumatology, 2014
Introduction. Antitumor necrosis factor-alpha (TNF-α) agents are widely used for treatment of rheumatic and dermatological diseases. We conducted the systematic review and meta-analysis to assess the prevalence of HBV reactivation among patients treated ...
F. Cantini, S. Boccia, D. Goletti, F. Iannone, E. Leoncini, N. Panic, F. Prignano, G. Gaeta   +7 more
semanticscholar   +1 more source

Under Development JAK Inhibitors for Dermatologic Diseases

Mediterranean Journal of Rheumatology, 2020
Molecular targeting therapies represent a new exciting era in dermatology. A promising novel drug class, subject of intense research, is Janus kinase (JAK) inhibitors.
N. Sideris, E. Vakirlis, A. Tsentemeidou, Alexandra Kourouklidou, D. Ioannides, E. Sotiriou   +5 more
semanticscholar   +1 more source

Dermatological pharmacology: topical agents [PDF]

Medicine, 2009
Topical therapies constitute an important aspect of dermatological treatments. This article covers the principles of topical treatments, the vehicles used and a number of commonly used topical agents, including corticosteroids. Indications for use and common adverse effects of these topical agents are outlined.
Vincent Cy. Li, Mahbub M. U. Chowdhury
openaire   +1 more source

Topical Immunomodulation with Diphenlycyclopropenone for Alopecia Areata

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2019
Introduction: Topical immunotherapy with diphenylcyclopropenone is a treatment option for patients with refractory or extensive alopecia areata. The aim of this study was to evaluate the clinical efficacy and tolerability of diphenylcyclopropenone ...
Ana Sofia Borges, Ana Brasileiro, Rita Ramos Pinheiro, André Lencastre   +3 more
doaj   +1 more source